Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Randomized Clinical Trial
100%
Danegaptide
100%
Acute Myocardial Infarction Patients
100%
Primary Percutaneous Coronary Intervention (pPCI)
100%
ST-elevation Myocardial Infarction (STEMI)
33%
Myocardial Salvage
25%
Clinical Outcomes
8%
Therapeutic Potential
8%
Placebo
8%
High Dose
8%
Small Vessel Disease
8%
Trial Registration
8%
Myocardial Infarction Patients
8%
Left Ventricular Ejection Fraction
8%
Gap Junction
8%
Imaging Criteria
8%
Ischemic Insult
8%
Dose Level
8%
Cardiac Magnetic Resonance Imaging (cMRI)
8%
Myocardial Injury
8%
Final Infarct Size
8%
Two-dose
8%
Reperfusion
8%
Infarct-related Artery
8%
Myocardial Salvage Index
8%
Thrombolysis in Myocardial Infarction Flow
8%
Ischemic Time
8%
Proof of Concept Study
8%
Registration number
8%
Differences between Groups
8%
Per-protocol Analysis
8%
Reperfusion Injury
8%
Medicine and Dentistry
Myocardial Infarction
100%
Acute Heart Infarction
100%
Primary Percutaneous Coronary Intervention
100%
Danegaptide
100%
Randomized Clinical Trials
100%
ST Segment Elevation Myocardial Infarction
33%
Infarction
16%
Placebo
8%
Ischemia
8%
Heart Left Ventricle Ejection Fraction
8%
Gap Junction
8%
Drug Megadose
8%
Low Drug Dose
8%
Blood Clot Lysis
8%
Cardiac Magnetic Resonance Imaging
8%
Reperfusion Injury
8%
Heart Muscle Injury
8%
Diseases
8%
Peptide
8%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
100%
Randomized Clinical Trial
100%
Danegaptide
100%
ST Segment Elevation Myocardial Infarction
33%
Infarction
16%
Heart Infarction
8%
Placebo
8%
Ischemia
8%
Reperfusion Injury
8%
Heart Muscle Injury
8%
Diseases
8%
Peptide
8%
Low Drug Dose
8%